[CLSTR]
< Back to situation

[REVISION HISTORY]

Advancements in Italian oncology and radiotherapy

Updated 2 times since CLSTR started tracking revisions of this situation.

What changed

2026-09-09 10:44 UTC → 2026-09-09 14:29 UTC · added removed

Italian medical institutions and researchers continue to advance oncology through specialized training and international scientific leadership. To support genomic cancer profiling for approximately 15,000 eligible patients annually, the University of Milan is launching the second edition of a Level II University Master in ‘Molecular Pathology and Molecular Tumor Board’. This initiative, involving the National Cancer Institute, IEO, Niguarda Cancer Center, and the Lombardy Region, aims to train professionals to translate molecular data into clinical decisions. Such multidisciplinary teams have been shown to improve disease control time, particularly for patients with advanced illness. In the field of breast cancer, reports indicate that over 30,000 genomic tests have been prescribed in Italy for early-stage cases since 2020. Experts suggest expanding this usage, noting that approximately However, a gap in coverage persists; in 2025, only 9,800 genomic tests were performed for early-stage HR+/HER2- breast cancer, compared to an estimated 13,000 women could benefit annually. eligible patients. Experts from AIOM and Europa Donna Italia emphasize the need for increased funding and the integration of these tests into the Essential Levels of Care (LEA) to ensure nationwide availability and reduce regional disparities. These tests are critical for predicting recurrence risks and could potentially reduce chemotherapy use by 48% in specific HR+/HER2- carcinoma cases. Concurrently, Italian researchers are maintaining global recognition in radiotherapy. Professor Stefano Arcangeli has been ranked first globally for scientific publications regarding hypofractionated radiotherapy for prostate cancer, leading with 32 publications and 1,200 citations. His research focuses on techniques that reduce treatment sessions while maintaining precision. Additionally, Giampaolo Montesi of San Salvatore Hospital has participated in an international consensus group to establish new clinical standards and guidelines for image-guided radiotherapy for upper gastrointestinal tumors, including pancreatic and hepatic treatments.

Versions

  1. 2026-09-09 14:29 UTC Advancements in Italian oncology and radiotherapy
  2. 2026-09-09 10:44 UTC Advancements in Italian oncology and radiotherapy
  3. 2026-09-09 05:44 UTC Advancements in Italian oncology and radiotherapy

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.